Despite proven efficacy of osteoporosis medications, patients turn to dietary supplements marketed for bone health that lack ...

Inflammatory bowel disease (IBD) and autoimmune liver disease (AILD) prevalence are significantly correlated, according to a study in the Journal of Gastroenterology and Hepatology. The findings are ...

Most women with hyperemesis gravidarum report "major impacts" on their social life, work, and sleep, as well as depression and anxiety.

Growing evidence suggests that Chagas disease, spread by the triatomine insect, may be becoming endemic in the US.

Ingredients not on the green list for GLP-1 drugs in compliance with FDA standards are subject to detention without examination at the border.

A scientific statement regarding evidence-based interventions for community CVD prevention has been published by the AHA.

Out-of-pocket spending decreased in states that gained protections from the No Surprises Act after its implementation in 2022.

Results of a systematic review showed that cognitive impairment and neuropsychiatric manifestations are common among patients with various forms of vasculitis.

Extended treatment with benralizumab led to durable remission, reduced OGC burden, sustained eosinophil depletion, and low relapse rates in patients with EGPA.

Children's exposure to medications, supplements, and psychoactive substances increased, especially exposures linked to suicidal intent.

An analysis of postmarketing safety data for anifrolumab in SLE found AEs that were not previously listed on labeling materials, including dyspnea, pyrexia, and vomiting.

Physicians significantly underestimated the proportion of patients with systemic sclerosis who experienced pain, with rates of 43.4% vs 96.0%.